Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies.
J Labelled Comp Radiopharm
; 61(3): 291-298, 2018 03.
Article
in En
| MEDLINE
| ID: mdl-28857231
The dopamine D2-like receptors (ie, D2/3 receptors) have been the most extensively studied CNS receptor with Positron Emission Tomography (PET). The 3 different radiotracers that have been used in these studies are [11 C]raclopride, [18 F]fallypride, and [11 C]PHNO. Because these radiotracers have a high affinity for both dopamine D2 and D3 receptors, the density of dopamine receptors in the CNS is reported as the D2/3 binding potential, which reflects a measure of the density of both receptor subtypes. Although the development of D2- and D3-selective PET radiotracers has been an active area of research for many years, this by and large presents an unmet need in the area of translational PET imaging studies. This article discusses some of the challenges that have inhibited progress in this area of research and the current status of the development of subtype selective radiotracers for imaging D3 and D2 dopamine receptors with PET.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Dopamine D2
/
Radiopharmaceuticals
/
Positron-Emission Tomography
/
Receptors, Dopamine D3
Language:
En
Journal:
J Labelled Comp Radiopharm
Year:
2018
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom